Clinical Trials

Orthopaedic Trials

Osteoarthritis
Synvisc® (hylan G-F 20) for hip – U.S.	Phase 3

Genzyme is conducting a clinical study to evaluate the safety and efficacy of Synvisc^® in patients with pain due to hip osteoarthritis.

Osteoarthritis
Synvisc® for ankle, shoulder– Europe	Phase 3

Genzyme is conducting several clinical studies designed to evaluate the safety and efficacy of Synvisc^® in patients with pain due to ankle or shoulder osteoarthritis.

Osteoarthritis
Hylastan for knee	Phase 2

Genzyme is conducting a clinical study to evaluate the safety and efficacy of hylastan in patients with pain associated with osteoarthritis of the knee.

Osteoarthritis
Small Molecule	Preclinical

Genzyme is conducting studies of a small molecule therapy, which may be used to prevent cartilage degradation in osteoarthritis patients.

Knee Cartilage Damage
Carticel®II	Preclinical

Genzyme is conducting preclinical studies of a next-generation Carticel, which may require only minimally invasive or arthroscopic surgery.

Adhesion prevention for arthroscopic joint repair
Sepragel® Ortho	Preclinical

Sepragel Ortho for adhesion prevention following surgery is currently in preclinical studies.

Postoperative pain
Drug delivery	Preclinical

Our postoperative pain management program is currently in preclinical studies.